Synaptic AMPA receptor subunit trafficking is independent of the C terminus in the GluR2-lacking mouse

od Panicker, Sandip, Brown, Keith, Nicoll, Roger A.
Izdano 2008

Classical Complement Pathway Activation in ITP: Inhibition by a novel C1s inhibitor

od Peerschke, Ellinor I. B., Panicker, Sandip, Bussel, James
izdano v Br J Haematol (2015)

Evidence for a Centrally Located Gate in the Pore of a Serotonin-Gated Ion Channel

od Panicker, Sandip, Cruz, Hans, Arrabit, Christine, Slesinger, Paul A.
izdano v J Neurosci (2002)

Uncoupling complement C1s activation from C1q binding in apoptotic cell phagocytosis and immunosuppressive capacity

od Colonna, Lucrezia, Parry, Graham C., Panicker, Sandip, Elkon, Keith B.
izdano v Clin Immunol (2016)

C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro

od Nikitin, Pavel A., Rose, Eileen L., Byun, Tony S., Parry, Graham C., Panicker, Sandip
izdano v J Immunol (2019)

Complement-Mediated Enhancement of Monocyte Adhesion to Endothelial Cells by HLA Antibodies, and Blockade by a Specific Inhibitor of the Classical Complement Cascade, TNT003

od Valenzuela, Nicole M., Thomas, Kimberly A., Mulder, Arend, Parry, Graham C., Panicker, Sandip, Reed, Elaine F.
izdano v Transplantation (2017)

Real-Time Imaging of Discrete Exocytic Events Mediating Surface Delivery of AMPA Receptors

od Yudowski, Guillermo A., Puthenveedu, Manojkumar A., Leonoudakis, Dmitri, Panicker, Sandip, Thorn, Kurt S., Beattie, Eric C., von Zastrow, Mark
Izdano 2007

A Randomized, First‐in‐Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway

od Bartko, Johann, Schoergenhofer, Christian, Schwameis, Michael, Firbas, Christa, Beliveau, Martin, Chang, Colin, Marier, Jean‐Francois, Nix, Darrell, Gilbert, James C., Panicker, Sandip, Jilma, Bernd
izdano v Clin Pharmacol Ther (2018)

Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009—Results from a Randomized First-in-Human...

od Mühlbacher, Jakob, Jilma, Bernd, Wahrmann, Markus, Bartko, Johann, Eskandary, Farsad, Schörgenhofer, Christian, Schwameis, Michael, Parry, Graham C., Gilbert, James C., Panicker, Sandip, Böhmig, Georg A.
izdano v Transplantation (2017)

AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist

od Gever, Joel R, Soto, Rothschild, Henningsen, Robert A, Martin, Renee S, Hackos, David H, Panicker, Sandip, Rubas, Werner, Oglesby, Ian B, Dillon, Michael P, Milla, Marcos E, Burnstock, Geoffrey, Ford, Anthony PDW
Izdano 2010

Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial

od Jäger, Ulrich, D’Sa, Shirley, Schörgenhofer, Christian, Bartko, Johann, Derhaschnig, Ulla, Sillaber, Christian, Jilma-Stohlawetz, Petra, Fillitz, Michael, Schenk, Thomas, Patou, Gary, Panicker, Sandip, Parry, Graham C., Gilbert, James C., Jilma, Bernd
izdano v Blood (2019)